Soleno Therapeutics Inc (NAS:SLNO)
$ 57.31 -1.87 (-3.16%) Market Cap: 2.47 Bil Enterprise Value: 2.30 Bil PE Ratio: 0 PB Ratio: 8.89 GF Score: 32/100

Soleno Therapeutics Inc at Destiny-PWS Transcript

Oct 20, 2020 / NTS GMT
Release Date Price: $28.05
Susan Hedstrom
Foundation for Prader-Willi Research - Moderator

Welcome, everyone, to today's presentation. I love how those of you who have been joining us on previous sessions today recognize that the music was not playing on that video. I love listening to that video. Every time I watch it, it almost brings tears to my eyes because it reminds me of how much our community and our kids are working together to find treatments for PWS. And that's why I'm so thrilled to have today's presentation, which is a return of results presentation.

So to kick off today's session, I would like to present to you, Anish Bhatnagar, CEO of Soleno Therapeutics.

Anish Bhatnagar
Soleno Therapeutics Inc. - CEO

Thank you, Susan. My name is Anish Bhatnagar. I'm the CEO of Soleno Therapeutics. Also one of the physicians involved in the DCCR development program at the company. I'm really thankful to FPWR for giving us the opportunity to speak here today. And also, shoutout to Susan for the amazing job she's doing keeping this train running. It's a challenging time with all of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot